FLT3LG and neoplasm: This is particularly relevant for achieving robust FLT3L expression, as the poor stability of this cytokine limits its bioavailability52, and frequent administrations of recombinant FLT3L are necessary to obtain therapeutic effects in mouse tumor models18,53.